Interestingly, a post mortem histopathological study showed higher levels of astrocytic GLT-1 in the entorhinal cortex of non-demented subjects with AD brain pathology compared to AD subjects with dementia [94], suggesting that GLT-1 could contribute to preserving cognitive functions. This evidence concerns the gene SLC1A2 and Alzheimer disease.